PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
46 hedge funds and large institutions have $116M invested in PLx Pharma Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 3 reducing their positions, and 6 closing their positions.
533% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 3
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
80% more capital invested
Capital invested by funds: $64.3M → $116M (+$51.3M)
24% more funds holding
Funds holding: 37 → 46 (+9)
54% less call options, than puts
Call options by funds: $1.72M | Put options by funds: $3.76M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MS
Maven Securities
St Helier,
Jersey
|
+$5.92M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$3.28M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$2.48M |
| 4 |
Two Sigma Advisers
New York
|
+$2.24M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.57M |
| 2 |
PA
Perceptive Advisors
New York
|
-$1.95M |
| 3 |
Renaissance Technologies
New York
|
-$824K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$449K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$251K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| – | -$45K | -5,012 | Closed |
|
52
Bank of America
Charlotte,
North Carolina
| – | +$118 | +10 | New |
|
PLXP Hedge Fund Activity: Q2 2021 in Review
46 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2021, worth a combined $116M — up 80% from $64.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new PLXP positions and 6 closed out — a net gain of 9 holders — while 19 added to existing stakes and 3 trimmed.
The largest buyer was Maven Securities, opening a new position worth an estimated $5.92M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $4.57M sold.
- 46 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2021, up from 37 in Q1 2021.
- Funds reported $116M of PLx Pharma Inc. Common Stock stock for Q2 2021, up 80% quarter-over-quarter.
- 15 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2021 and 6 closed out, a net change of +9 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2021 was Maven Securities, an estimated $5.92M added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2021 was Stonepine Capital Management, an estimated $4.57M sold.
Based on aggregated 13F filings for Q2 2021.